Evaluating the Safety and Immunogenicity of PENNVAX®-GP DNA Vaccine and IL-12 Plasmid, Delivered Via Intradermal or Intramuscular Electroporation in Healthy, HIV-Uninfected Adults
Clinical trial NCT02431767 · COMPLETED
Trial details
- NCT number
- NCT02431767
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-08-01
- Primary completion
- 2017-06-08
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.